Endovascular Magnesium Sampling in Acute Stroke
| Status: | Completed |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | March 2012 |
| End Date: | March 2014 |
| Contact: | William J Mack, MD |
| Email: | mackw@usc.edu |
| Phone: | 323-226-7421 |
Magnesium Therapy: a Novel Platform for Neuroprotectant Sampling in Acute Stroke
This investigation will address the safety and feasibility of distal, intra-arterial
sampling through endovascular access, in acute stroke patients. Levels of Magnesium will be
measured in the region of infarct in patients who had been treated with intravenous
Magnesium therapy following an acute stroke. This study attempts to address whether the
traditional intravenous means of neuroprotectant administration achieves adequate
concentration of the therapeutic agent in the area of diseased tissue.
Inclusion Criteria:
1. Patient with acute cerebral ischemia due to ICA or MCA occlusion,
2. Patient already enrolled in the NIH FAST-MAG clinical trial,
3. Patient's clinical attending physician plans mechanical embolectomy procedure as part
of routine clinical care.
4. Age 40-95 inclusive (age criteria for FAST-MAG Trial).
Exclusion Criteria:
1. Technical inability to navigate microcatheter to target clot.
2. Patient or surrogate unavailable for consent
We found this trial at
2
sites
Click here to add this to my saved trials
Los Angeles, California 90009
Click here to add this to my saved trials